EMEA-001142-PIP02-16
Key facts
| Invented name |
Zerbaxa
|
| Active substance |
|
| Therapeutic area |
Infectious diseases
|
| Decision number |
P/0277/2017
|
| PIP number |
EMEA-001142-PIP02-16
|
| Pharmaceutical form(s) |
Powder for concentrate for solution for infusion
|
| Condition(s) / indication(s) |
Treatment of pneumonia
|
| Route(s) of administration |
Intravenous use
|
| Contact for public enquiries |
Merck Sharp & Dohme (Europe), Inc.
Tel. +31 412661521 |
| Decision type |
PM: decision on the application for modification of an agreed PIP
|